Corticosteroid-binding globulin regulates cortisol pharmacokinetics.
AffiliationDepartment of Endocrinology, Christie Hospital and Endocrine Sciences Research Group, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK . School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK . Department of Biochemistry, University Hospital of South Manchester, Wythenshawe, UK.
MetadataShow full item record
AbstractObjective: Corticosteroid-binding globulin (CBG) is the principal carrier for cortisol in the circulation. Variations in CBG binding capacity are predicted to alter total serum cortisol disposition, but free serum cortisol is believed to be unaffected. Unbound cortisol pharmacokinetics (PK) have not been studied in the context of CBG changes. We aimed to assess the regulation of cortisol PK by CBG. Design and subjects: Women on oestrogens (OCP), patients homozygous for a non-functioning CBG variant (CBG null) and healthy controls (HV) were studied before and after IV and oral administration of hydrocortisone 20mg. Measurements: PK parameters were studied for total serum cortisol (SerF), free serum cortisol (FreeF) and cortisone (FreeE), and salivary cortisol (SalF) and cortisone (SalE): area under the curve (AUC), clearance (CL), half-life, and volume of distribution (Vd). Results: Following IV hydrocortisone, AUC and half-life of SerF were significantly higher in the OCP group and lower in the CBG null. SerF CL and Vd were significantly lower in the OCP group and increased in the CBG null, compared to HV. PK parameters for FreeF and the salivary biomarkers were not different between the CBG null and HV, although OCP patients still had higher AUC compared to HV and prolonged half-life. These findings were confirmed following oral hydrocortisone, but concentration-time profiles were highly heterogeneous and SalF interpretation was problematic due to oral contamination. Conclusions: We have demonstrated that CBG has a distinct effect on cortisol PK. When CBG binding is disrupted, FreeF retains normal PK characteristics, although CBG null patients lack a CBG-bound pool of readily releasable cortisol. Women on oestrogens may have altered free serum cortisol kinetics and thus may be potentially overexposed to glucocorticoids.
CitationCorticosteroid-binding globulin regulates cortisol pharmacokinetics. 2010: Clin Endocrinol
- Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches.
- Authors: Perogamvros I, Kayahara M, Trainer PJ, Ray DW
- Issue date: 2011 Jul
- Cortisol and ACTH responses to psychosocial stress are modulated by corticosteroid binding globulin levels.
- Authors: Kumsta R, Entringer S, Hellhammer DH, Wüst S
- Issue date: 2007 Sep-Nov
- Salivary cortisone is a potential biomarker for serum free cortisol.
- Authors: Perogamvros I, Keevil BG, Ray DW, Trainer PJ
- Issue date: 2010 Nov
- Corticosteroid-binding globulin: modulating mechanisms of bioavailability of cortisol and its clinical implications.
- Authors: Bae YJ, Kratzsch J
- Issue date: 2015 Oct
- Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin.
- Authors: Lewis JG, Bagley CJ, Elder PA, Bachmann AW, Torpy DJ
- Issue date: 2005 Sep